| 7.42 Data as of May 24 |  -0.03 / -0.40%Today’s Change | 3.86 Today|||52-Week Range 9.92 | +10.58% Year-to-Date |
| Previous close | 7.45 |
| Today’s open | 7.48 |
| Day’s range | 7.23 - 7.55 |
| Volume | 1,104,415 |
| Average volume (3 months) | 1,373,107 |
| Market cap | $839.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -152.63% |
| Earnings growth (this year) | -19.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.54% |
| P/E ratio | NM |
| Price/Sales | 17.61 |
| Price/Book | 17.12 |
| Today’s change | Today’s % change | |
|---|---|---|
| ITMNInterMune Inc | -0.38 | -3.82% |
| MNTAMomenta Pharmaceutic... | +0.08 | +0.60% |
| SZYMSolazyme Inc | +0.44 | +4.11% |
| GEVASynageva Biopharma C... | +0.29 | +0.71% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $42.3M |
| Annual profit (last year) | -$53.6M |
| Net profit margin | -126.53% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Gregory Ian Frost, PhD |
Vice President-Manufacturing & Operations William J. Fallon, PhD |
Corporate headquarters San Diego, California |
.
